4
total announcements
530207.BO · 15 min delayed
Brawn Biotech Ltd
Brawn Biotech Ltd has published its un-audited financial results for the quarter ended June 30, 2026, in compliance with Regulation 47 of SEBI (Listing Obligation and Disclosure Requirements), 2015.
Brawn Biotech Ltd
Brawn Biotech Ltd has announced its un-audited financial results for the quarter ended June 30, 2026, which were approved by the Board of Directors in a meeting held on August 13, 2026. The company reported revenue from operations of ₹ 217.18 crore, a decrease of 0.53% from the previous quarter. The net profit for the quarter stood at ₹ 4.05 crore, a decrease of 56.25% from the previous quarter.
Brawn Biotech Ltd
Brawn Biotech Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with revenue from operations at ₹ 217.18 crore and profit before tax at ₹ 4.15 crore. The company's board of directors has approved the financial results and also considered and approved the Boards' Report for the financial year ended March 31, 2026.
Brawn Biotech Ltd
Brawn Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve Un-Audited Financial Results for the quarter ended June 30, 2026.